Discontinuation report ONBREZ BREEZHALER
Report ID | 163682 |
Drug Identification Number | 02376938 |
Brand name | ONBREZ BREEZHALER |
Common or Proper name | ONBREZ BREEZHALER |
Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | INDACATEROL |
Strength(s) | 75MCG |
Dosage form(s) | CAPSULE |
Route of administration | INHALATION INHALATION |
Packaging size | 3 X 10 |
ATC code | R03AC |
ATC description | ADRENERGICS, INHALANTS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2022-07-01 |
Actual discontinuation date | 2022-07-01 |
Remaining supply date | 2022-10-31 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
Company contact information | customer.relations@novartis.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2022-07-14 | French | Compare |
v3 | 2022-07-14 | English | Compare |
v2 | 2022-06-29 | French | Compare |
v1 | 2022-06-29 | English | Compare |
Showing 1 to 4 of 4